NOS3 and endothelial dysfunction: In conclusion, the present data suggest that chronic etanercept treatment is likely able to prevent body weight gain and the development of endothelial dysfunction by restoring eNOS expression and reducing serum levels of TNF-α in CD-fed rats, indicating that TNF-α-mediated inflammation has a crucial role on endothelial dysfunction and body weight increment related with CD consumption.